1. Resources >>
  2. Companies directory >>
  3. Akrevia Therapeutics, Inc.
Akrevia Therapeutics, Inc.

Akrevia Therapeutics, Inc.

Akrevia Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics. The company’s proprietary Aklusion™ platform technology allows biologics to be specifically activated in the tumor microenvironment, and with precisely tailored properties, expanding the universe of natural immune-activating proteins that can be safely delivered. Akrevia is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for patients living with cancer. To learn more, please visit www.akrevia.com. The company is financed by blue chip investors F-Prime Capital Partners and Atlas Venture. Akrevia has licensed key technology from Thomas Jefferson University and City of Hope. The company is located in Cambridge, Massachusetts.
Headquarters
Cambridge, Massachusetts
Company size
10,001+ employees
Specialties
Biotechnology, Immunotherapeutics
Top employees at
Akrevia Therapeutics, Inc.
M
Margaret Karow
VICE PRESIDENT DISCOVERY AND PRECLINICAL DEVELOPMENT
Camarillo, California
M
Magali Pederzoli
maître de Conférence en Immunologie
Cambridge, Massachusetts
R
Ronan OHagan
Senior Vice President, Discovery
Greater Boston Area

Companies, you might be interested in:

Akribeia EPG PTE
Akrid Software Inc.
The most popular email templates:
Akrevia Therapeutics, Inc.’s email formatsPercentage
lastName_firstNameInitialdoe_j@akrevia.com88%
firstNameInitial-lastNameInitialj-d@akrevia.com40%
lastNamefirstNamedoejane@akrevia.com95%
lastName_firstNamedoe_jane@akrevia.com49%
lastNamefirstNameInitialdoej@akrevia.com32%
lastName-firstNameInitialdoe-j@akrevia.com32%

Our Integration Partners

+ 13 more